EphA4 inhibitors (Iron Horse Therapeutics)

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameEphA4 inhibitors (Iron Horse Therapeutics)
Drug Alias NameN/A
ClassificationSmall molecules
Mechanisms of ActionErythropoietin-producing hepatocellular receptor A4 blockersNeuroprotectants
TargetsErythropoietin-producing hepatocellular receptor A4
Therapy Area/IndicationsAmyotrophic Lateral Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesSanford Burnham Prebys Medical Discovery Institute
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesIron Horse Therapeutics Inc
Active IndicationsN/A
Inactive IndicationsAmyotrophic Lateral Sclerosis

Other Information

ATC CodeN/A
Related LinksN/A